| |
| |
|
| Insider
Information: |
Nash Duane |
| Relationship: |
Executive Chairman, Di... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
37,531 |
|
|
Indirect Shares
|
9,224 |
|
|
| Direct
Value |
$42,884 |
|
|
|
Indirect Value
|
$11,438 |
|
|
| Total
Shares |
46,755 |
|
|
| Total
Value |
$54,321 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -21.4%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Akebia Therapeutics, Inc. |
AKBA |
|
2018-02-15 |
21,499 |
|
0 |
Premium* |
|
|
Immunic Inc |
IMUX |
Executive Chairman, Di... |
2022-05-12 |
16,032 |
2014-04-16 |
9,224 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IMUX |
Immunic Inc |
Executive Chairman |
• • – |
2022-05-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
6,000 |
16,032 |
0 |
- |
|
| IMUX |
Immunic Inc |
Executive Chairman |
• • – |
2022-05-12 |
4 |
B |
$5.03 |
$50,300 |
D/D |
10,000 |
22,032 |
2.81 |
% |
|
| IMUX |
Immunic Inc |
Executive Chairman |
• • – |
2021-08-10 |
4 |
B |
$9.80 |
$9,800 |
D/D |
1,000 |
15,032 |
2.81 |
% |
|
| IMUX |
Immunic Inc |
Executive Chairman |
• • – |
2021-05-12 |
4 |
B |
$12.75 |
$51,000 |
D/D |
4,000 |
14,032 |
2.81 |
% |
|
| IMUX |
Immunic Inc |
Director |
– • – |
2019-12-04 |
4 |
AS |
$6.96 |
$30,624 |
D/D |
(4,400) |
10,032 |
0 |
- |
|
| IMUX |
Immunic Inc |
Director |
– • – |
2019-12-03 |
4 |
D |
$7.15 |
$56,732 |
D/D |
(7,930) |
14,432 |
0 |
- |
|
| IMUX |
Immunic Inc |
Director |
– • – |
2019-12-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,157 |
22,362 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
|
– • – |
2018-02-15 |
4 |
AS |
$14.62 |
$14,620 |
D/D |
(1,000) |
21,499 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
|
– • – |
2017-10-02 |
4 |
AS |
$19.64 |
$23,332 |
D/D |
(1,188) |
22,499 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
|
– • – |
2017-07-03 |
4 |
AS |
$14.27 |
$14,127 |
D/D |
(990) |
23,687 |
0 |
- |
|
| IMUX |
Immunic Inc |
President |
• – – |
2017-06-08 |
4 |
B |
$3.12 |
$12,182 |
D/D |
3,900 |
8,224 |
2.74 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
|
– • – |
2017-04-03 |
4 |
AS |
$9.20 |
$9,119 |
D/D |
(991) |
24,677 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
|
– • – |
2017-01-03 |
4 |
AS |
$10.46 |
$20,711 |
D/D |
(1,980) |
25,668 |
0 |
- |
|
| IMUX |
Immunic Inc |
President |
• – – |
2016-12-23 |
5 |
GD |
$0.00 |
$0 |
D/D |
5,000 |
4,324 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
|
– • – |
2016-10-03 |
4 |
AS |
$8.96 |
$17,746 |
D/D |
(1,981) |
27,648 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
|
– • – |
2016-07-06 |
4 |
AS |
$7.48 |
$14,819 |
D/D |
(1,980) |
29,629 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
Director |
– • – |
2015-10-02 |
4 |
AS |
$8.65 |
$8,617 |
D/D |
(996) |
31,609 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
Director |
– • – |
2015-07-02 |
4 |
AS |
$9.53 |
$9,490 |
D/D |
(996) |
32,605 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
Director |
– • – |
2015-04-02 |
4 |
AS |
$9.09 |
$9,052 |
D/D |
(996) |
12,016 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
Director |
– • – |
2015-04-01 |
4 |
A |
$9.51 |
$18,830 |
D/D |
1,980 |
13,012 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
Director |
– • – |
2015-01-02 |
4 |
AS |
$11.46 |
$11,403 |
D/D |
(995) |
12,814 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
Director |
– • – |
2015-01-01 |
4 |
A |
$11.64 |
$23,047 |
D/D |
1,980 |
13,809 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
Director |
– • – |
2014-12-26 |
4 |
AS |
$11.19 |
$57,846 |
D/D |
(5,169) |
11,829 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
Director |
– • – |
2014-12-24 |
4 |
AS |
$11.26 |
$76,189 |
D/D |
(6,764) |
16,998 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
Director |
– • – |
2014-12-23 |
4 |
A |
$11.54 |
$274,213 |
D/D |
23,762 |
23,762 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
